Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bacterial ghosts as adjuvant particles.

Eva M Riedmann1, Jennelle M Kyd, Allan W Cripps

  • 1Department of Chromosome Biology, Max F Perutz Laboratories, University of Vienna, Vienna, Austria. eva.riedmann@univie.ac.at

Expert Review of Vaccines
|April 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bacterial Ghosts as Innovative Transport Vehicles for Platinum-Based Anticancer Drugs.

ChemMedChem·2026
Same author

Gut Microbiome and Metabolic and Immune Indices in Males with or without Evidence of Metabolic Dysregulation.

Journal of obesity & metabolic syndrome·2024
Same author

Assessment of a Multispecies Probiotic Supplement for Relief of Seasonal Allergic Rhinitis: A Randomized Double-Blind Placebo-Controlled Trial.

Journal of integrative and complementary medicine·2023
Same author

Novel Salinomycin-Based Paramagnetic Complexes-First Evaluation of Their Potential Theranostic Properties.

Pharmaceutics·2022
Same author

Court finds no Vaccines-autism link.

Human vaccines·2022
Same author

Australian Aboriginal Otitis-Prone Children Produce High-Quality Serum IgG to Putative Nontypeable <i>Haemophilus influenzae</i> Vaccine Antigens at Lower Titres Compared to Non-Aboriginal Children.

Frontiers in cellular and infection microbiology·2022

Bacterial ghosts (BGs) are novel vaccine delivery systems with built-in adjuvant properties. These bacterial cell envelopes can enhance immune responses to delivered antigens, addressing the need for improved vaccine adjuvants.

Area of Science:

  • Vaccinology
  • Immunology
  • Biotechnology

Background:

  • New-generation vaccines (recombinant protein/DNA) often exhibit lower immunogenicity and reactogenicity than traditional vaccines.
  • There is a critical need for advanced vaccine adjuvants to improve vaccine efficacy.
  • Bacterial ghosts (BGs) are being explored as a promising vaccine delivery platform with inherent adjuvant capabilities.

Purpose of the Study:

  • To investigate the potential of bacterial ghosts (BGs) as a vaccine delivery system.
  • To evaluate the intrinsic adjuvant properties of BGs for enhancing immune responses.
  • To explore BGs for their ability to improve the immunogenicity of delivered antigens.

Main Methods:

  • Utilizing bacterial ghosts (BGs), which are nonliving cell envelopes from Gram-negative bacteria.

Related Experiment Videos

  • Preserving the cellular morphology and native surface antigenic structures of BGs.
  • Leveraging the particulate nature and inherent immune-stimulating compounds of BGs.

    • Main Results:

    • BGs maintain their native structure and surface antigens.
    • The particulate nature of BGs contributes to their adjuvant potential.
    • BGs contain known immune-stimulating compounds that can enhance immune responses.

    Conclusions:

    • Bacterial ghosts (BGs) show significant potential as effective vaccine delivery systems.
    • The intrinsic adjuvant properties of BGs can enhance immune responses to co-delivered antigens.
    • BGs represent a promising strategy for developing next-generation vaccines with improved efficacy.